IVSED Response to PMPRB Proposed Guidelines
Independent Voices for Safe and Effective Drugs (IVSED) response to proposed guidelines for the Patented Medicines Price Review Board a must read. IVSED is a coalition of academics, researchers and […]
Category Archives: Patient Advocacy
Shining Light on (So-called) Informed Consent to Clinical Trials
Research Ethics in Clinical Pharmacology Tens of thousands of clinical trials involving drugs are taking place each year. When the researchers are clinicians, they often recruit amongst their patients. Given […]
Brief to the Health Standing Committee of the House of Commons
Introduction For the past two decades in Canada, patient groups funded by pharmaceutical companies have dominated public conversations about the effectiveness and safety of prescription drugs. These groups receive unrestricted […]
Reporting Adverse Side Effects: If You Don’t Tell, Who Will?
Adverse drug reactions (ADRs) are an important part of the process of determining the safety of drugs and treatments. Reports of ADRs by consumers has become a significant portion of the total yet only 1-5% of ADRs are ever reported. The consumer has the biggest stake in ensuring that ADRs are documented and that pharmaceutical manufacturers are held accountable for their mistakes.
The Overdiagnosis of Cancer: When the Diagnosis Undermines the Quality of Life
The overdiagnosis of diseases like cancer provides no life-saving benefit yet can greatly decrease the patients’ quality of life because of the side effects of the treatments and unjustified fear of a disease that does not threaten their lives.
PharmaWatch Canada 